Max Bronstein, an industry leader whose work as a mission-driven consultant emphasized precision-medicine approaches for rare disease and health policy, has taken on a new challenge as Assistant Director for Health Innovation at the White House Office of Science and Technology Policy.
Prior roles include:
- Principal – MGB Consulting
- Senior Director, Health Policy & Corporate Affairs – Audentes Therapeutics
- Chief Advocacy & Science Policy Officer – EveryLife Foundation for Rare Diseases
